Research Article
Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Table 1
Patients characteristics (n (%)).
| Characteristic | GEM-IRE group (n = 30) | IRE group (n = 30) | value |
| Sex | F | 16 (53.3) | 18 (60.0) | 0.795 | M | 14 (46.7) | 12 (40) | |
| Mean age (years) | 61 (43–78) | 67 (47–75) | | Lesion size (cm) | 3.8 (2.1–4.7) | 4.1 (2.3–4.6) | | Tumor location | | | 0.763 | Head | 7 (23.3) | 8 (26.7) | | Body | 12 (40.0) | 15 (50.0) | | Tail | 7(23.3) | 4 (13.3) | | Uncinate process | 4 (13.4) | 3 (10.0) | |
| Preoperative surgical therapy | | | 0.624 | None | 23 (76.6) | 25 (83.4) | | Gastrojejunostomy | 2 (6.7) | 1 (3.3) | | Hepaticojejunostomy | 1 (3.3) | 1 (3.3) | | Double bypass | 2 (6.7) | 0 (0.0) | | Others | 2 (6.7) | 3 (10.0) | |
| PS | | | 0.627 | 0 | 8 (26.7) | 5 (16.7) | | 1 | 18 (60.0) | 22 (73.3) | | 2 | 4 (13.3) | 3 (10.0) | |
|
|
PS: performance status.
|